Long Intraaortic Balloon Treatment Time Leads to More Vascular Complications

Abstract

Intraaortic balloon counterpulsation is an established and efficient therapy. Limb ischemia is the most common complication. The impact of treatment duration on balloon-related complications was analyzed retrospectively in 135 patients who underwent balloon counterpulsation between 1998 and 2004. Thirty high-risk coronary patients required preoperative intraaortic balloon therapy, 41 were in preoperative cardiogenic shock, and 64 needed support for difficulties in weaning from cardiopulmonary bypass. No balloon-related mortality occurred. The overall balloon-related complication rate was 20/135 (14.8%); 18 had limb ischemia, of whom 6 (4.4%) required vascular interventions. Intraaortic balloon treatment time was significantly longer in patients who developed limb ischemia (99.8 ± 54.1 h) compared to those who did not (34.4 ± 30.4 h). Preoperative therapy had short treatment times and few complications. Intraaortic balloon pumping provides effective circulatory support with a low complication rate. A clear relationship was established between duration of treatment and balloon-related complications. Independent risk factors for balloon-related complications were long treatment time, acute myocardial infarction, age over 65 years, and ejection fraction less than 0.30.

Get full access to this article

View all access options for this article.

References

Kantrowitz

Tjonneland

Freed

Phillips

Butner

Sherman

Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA 1968; 203: 113–8.

Baskett

Ghali

Maitland

Hirsch

. The intraaortic balloon pump in cardiac surgery [Review]. Ann Thorac Surg 2002; 74: 1276–87.

Ferguson

3rd Cohen

Freedman

Jr Stone

Miller

Joseph

. The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. J Am Coll Cardiol 2001; 38: 1456–62.

Stone

Ohman

Miller

Joseph

Christenson

Cohen

. Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction. J Am Coll Cardiol 2003; 41: 1940–5.

Gutfinger

Ott

Miller

. Aggressive preoperative use of intraaortic balloon pump in elderly patients undergoing coronary artery bypass grafting. Ann Thorac Surg 1999; 67: 610–3.

Christenson

Badel

Simonet

Schmuziger

. Preoperative intraaortic balloon pump enhances cardiac performance and improves outcome of redo CABG. Ann Thorac Surg 1997; 64: 1237–44.

Craver

Murrah

. Elective intraaortic counterpulsation for high-risk off-pump coronary artery bypass operations. Ann Thorac Surg 2001; 71: 1220–3.

Fasseas

Cohen

Kopistansky

Bowers

McCormick

Kasper

. Pre-operative intra-aortic balloon counterpulsation in stable patients with left main coronary disease. J Invasive Cardiol 2001; 13: 679–83.

Christenson

Schmuziger

Simonet

. Effective surgical management of high-risk coronary patients using preoperative intra-aortic balloon counterpulsation therapy. Cardiovasc Surg 2001:9: 383–90.

10.

Holman

Kiefe

McGriffin

Peterson

Allman

. Prophylactic value of preincision intra-aortic balloon pump: analysis of a statewide experience. J Thorac Cardiovasc Surg 2000; 120: 1112–9.

11.

Cohen

Ferguson

Freedman

Miller

Reddy

Ohman

. Comparison of outcomes after 8 vs. 9.5 French size intra-aortic balloon counterpulsation catheters based on 9,332 patients in the Benchmark registry. Catheter Cardiovasc Interv 2002; 56: 200–6.

12.

Mand'Ak

Lonsky Dominik

Zacek

. Vascular complications of the intra-aortic balloon counterpulsation. Angiology 2005; 56: 69–74.

13.

Elahi

Chetty

Kirke

Azeem

Hartshorne

Spyt

. Complications related to intra-aortic balloon pump in cardiac surgery: a decade later. Eur J Vasc Endovasc Surg 2005; 29: 591–4.

14.

Cohen

Dawson

Kopistansky

McBride

. Sex and other predictors of intra-aortic balloon counterpulsation-related complications: prospective study of 1119 consecutive patients. Am Heart J 2000; 139: 282–7.

15.

Christenson

Cohen

Ferguson

3rd Freedman

Miller

Ohman

. Trends in IABP complications and outcomes in cardiac surgery. Ann Thorac Surg 2002:74: 1086–91.

16.

Erdogan

Goksedef

Erentug

Polat

Bozbuga

Mansuroglu

. In which patients should sheathless IABP be used? An analysis of vascular complications in 1211 cases. J Card Surg 2006; 21: 342–6.

17.

Manord

Garrard

Mehra

Sternbergh

3rd Ballinger

Ventura

. Implications for the vascular surgeon with prolonged (3 to 89 days) intraaortic balloon pump counterpulsation. J Vasc Surg 1997; 26: 511–6.

18.

Christenson

Simonet

Schmuziger

. Economic impact of preoperative intraaortic balloon pump therapy in high-risk coronary patients. Ann Thorac Surg 2000; 70: 510–5.

19.

Scholz

Ragab

von zur Muhlen

Schroder

Werner

Mindel

. Complications of intra-aortic balloon counterpulsation. The role of catheter size and duration of support in a multivariate analysis of risk. Eur Heart J 1998; 19: 458–65.

20.

Meharwal

Trehan

. Vascular complications of intra-aortic balloon insertion in patients undergoing coronary revascularization: analysis of 911 cases. Eur J Cardiothorac Surg 2002; 21: 741–7.